Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preloaded combination NRT for smoking cessation in Kazakhstan
NCT05484505Phase 1Unknown
- Sponsor
- Nazarbayev University
- Start
- Jul 2023
- Primary completion
- Dec 2024
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of nicotine patch in Tobacco Use Disorder (TUD), sponsored by Nazarbayev University. Primary endpoint: Self-reported smoking during intervention period at 12 months. Status: unknown.
02
Drugs
nicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT05484505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05484505.